Aug 14, 2021 by Steven DittoIllumina Delivers a Beat and a Raise in Q2According to CEO Francis deSouza, the genetic life-sciences company is "firing on all cylinders."
Aug 3, 2021 by Steven DittoIs It Too Late to Buy Idexx Laboratories?This pet healthcare company is giving vets what they need, and its stock has been doing the same for investors.
Jul 31, 2021 by Steven DittoBetter Buy: Vertex vs. CRISPRVertex might be undervalued, CRISPR Therapeutics might be overvalued, but both are looking for a home run.
Jul 29, 2021 by Steven DittoIs Moderna a Buy?Moderna is riding high on the COVID-19 wave. Is it too late to get in?
Jul 29, 2021 by Steven DittoIs Novavax a Buy?After moving at less than warp speed, can this vaccine company catch up to the global opportunity?
Jul 29, 2021 by Steven Ditto3 Things About Regeneron That Smart Investors KnowThe biotech's COVID-19 antibody cocktail made headlines last year, but there's a bigger story here.
Jul 23, 2021 by Steven Ditto3 Things About CRISPR Therapeutics That Smart Investors KnowThe company is on track to be the first to market with a gene-editing therapy for blood disorders.
Jul 22, 2021 by Steven Ditto3 Things About Vertex Pharmaceuticals That Smart Investors KnowCan one multibillion-dollar blockbuster breakthrough lead to another?
Jul 14, 2021 by Steven Ditto3 Things About Fulgent Genetics That Smart Investors KnowFew companies had bigger tailwinds from COVID-19. What comes next could be even more exciting.
Jul 14, 2021 by Steven DittoIs Illumina a Buy?Illumina has gained almost 29% this year and could be headed higher.
Jul 13, 2021 by Steven Ditto3 Things About Invitae That Smart Investors Should KnowCould Invitae become the first $1 trillion market cap healthcare company?
Jul 10, 2021 by Steven DittoWhere Will ARK Genomic Revolution ETF Be in 5 Years?Cathie Wood's genomics ETF is making big bets on the "Genomic Age."
Jul 10, 2021 by Steven DittoIs It Too Late to Buy Intellia Therapeutics?After skyrocketing 68% last week, will this stock keep running higher?
Jun 12, 2021 by Steven DittoHas Illumina Lost Its Shine?Cathie Wood lost her conviction and dumped the stock. Can Illumina get back on track?
Jun 11, 2021 by Steven DittoIs GoodRx the Prescription for Your Portfolio?You're probably paying too much for your drugs. Fortunately, there's some help on the way.
Jun 8, 2021 by Steven DittoWhat Does Life After COVID Look Like for Fulgent Genetics?Fulgent rode on a wave of COVID revenue. What comes next could be pretty special.
Jun 5, 2021 by Steven DittoIs Amazon Becoming a Healthcare Company?Amazon has set its sights on the $4 trillion U.S. healthcare market.
May 29, 2021 by Steven DittoCan Invitae Be the Winner-Take-Most in Genetic Testing?Just like in poker, in some markets, the winner can take the whole pot. Can Invitae take home all the chips?
May 27, 2021 by Steven DittoIs Intuitive Surgical the Tesla of Healthcare?Tesla hopes to dominate the car market using robots and artificial intelligence. Can Intuitive Surgical do the same in the operating room?
May 25, 2021 by Steven DittoTeladoc Health Is a Top ARK Holding. Should It Be One of Yours?Investors shouldn't follow just anyone into a stock. Cathie Wood, however, might be a great guide.
